MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Dr. Dansky Ullmann joins the Company as MaxCyte prepares for clinical testing of its first cell therapy drug candidate Brings more than 25 years of experience in clinical oncology and drug development GAITHERSBURG, Md., April 25, 2018 -- (Healthcare ... Biopharmaceuticals, Personnel MaxCyte, CARMA therapies, cell therapy, Flow Electroporation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2018 Category: Pharmaceuticals Source Type: news

Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease
Collaboration between China's National Center for Cardiovascular Diseases and Lilly aims to improve care for people living with Type 2 diabetes in China The Lilly and NCCD collaboration will address four strategic areas to advance scientific understandi... Biopharmaceuticals, Cardiology, Endocrinology Eli Lilly, diabetes, cardiovascular disease, diabetic kidney disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2018 Category: Pharmaceuticals Source Type: news

Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
FocalView is a first-of-its-kind app designed to modernize ophthalmic clinical trials, making them more accessible and flexible Using patients' self-recorded measurements, FocalView aims to enable more sensitive trial endpoints and more accurate patient... Biopharmaceuticals, Ophthalmology, Product Launch Novartis, FocalView (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2018 Category: Pharmaceuticals Source Type: news

Lin BioScience Announces FDA Orphan Drug Designation for LBS-007 for the Treatment of Acute Lymphoblastic Leukemia
Cancer cell cycle inhibitor is Lin BioScience's second candidate to receive Orphan Drug Designation SAN DIEGO, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Lin BioScience, a drug development company targeting unmet clinical needs in onco... Biopharmaceuticals, Oncology, FDA Lin BioScience, LBS-007, acute lymphoblastic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
LOS ANGELES, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris "GTBP.PA") today announced that Dr. Peter Kiener will join GT Biopharma's Board of Directors, effective immediately. Dr... Biopharmaceuticals, Oncology, Personnel GT Biopharma, Natural Killer Cell Engagers, lymphoma, leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
LEXINGTON, Mass., April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammato... Biopharmaceuticals, Ophthalmology Aldeyra Therapeutics, reproxalap, allergic conjunctivitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Urovant Sciences Strengthens Executive Management Team with Senior Hires and Establishes U.S. Headquarters in Irvine, California
Cornelia Haag-Molkenteller, former VP and Therapeutic Area Head, Clinical Development, for Urology, Women's Health, and Internal Medicine at Allergan, joins as Chief Medical Officer Michael McFadden, former SVP for Commercial at Avanir, joins as Chief C... Biopharmaceuticals, Urology, Personnel Urovant Sciences, Vibegron, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
Collagen Technology Mimics Nature, to Regenerate Bone and Cartilage NESS ZIONA, Israel, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will foc... Devices, Orthopaedic, Regenerative Medicine Datum Biotech, Datum Orthobiologics, bone graft, GLYMATRIX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Positive Late-Breaking Data From The INTREPID Study
MARLBOROUGH, Mass., April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, mul... Devices, Neurology Boston Scientific, INTREPID study, deep brain stimulation, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
INDIANAPOLIS, April 24, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today results from a post-hoc subgroup analysis which demonstrated efficacy of galcanezumab in patients with episodic and chronic migrain... Biopharmaceuticals, Neurology Eli Lilly, galcanezumab, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2018 Category: Pharmaceuticals Source Type: news

Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Company received FDA 510(k) clearance Continued progress in R&D whole-product solutions pipeline EDEN PRAIRIE, Minn. -- (Healthcare Sales & Marketing Network) -- Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologi... Devices, Interventional, FDA Surmodics, percutaneous transluminal angioplasty, balloon catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
The first generic version of Miglustat is now approved in the U.S. LYNDHURST, N.J. and CHIASSO, Switzerland, April 23rd, 2018 -- (Healthcare Sales & Marketing Network) -- Amerigen Pharmaceuticals Limited ("Amerigen") and Dipharma S.A. ("... Biopharmaceuticals, Generics, FDA, Product Launch Amerigen Pharmaceuticals, Dipharma, Miglustat, Zavesca (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
OrphoMed Founder Nikhilesh Singh, Ph.D. Appointed as Chief Scientific Officer; Will Remain as Board Member SAN FRANCISCO, April 23, 2018 -- (Healthcare Sales & Marketing Network) -- OrphoMed, Inc., a clinical-stage biopharmaceutical company developing... Biopharmaceuticals, Gastroenterology, Personnel OrphoMed, dimer therapeutic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Varex Imaging Names Rosebrough To Board Of Directors
SALT LAKE CITY, April 23, 2018 -- (Healthcare Sales & Marketing Network) -- Varex Imaging Corporation (Nasdaq: VREX) today announced that Walter M Rosebrough, Jr. has been appointed to the company's Board of Directors, effective April 20, 2018. Mr. Ros... Devices, Radiology, Personnel Varex Imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Clarus Appoints Former Ariad CEO Paris Panayiotopoulos as Operating Partner and Member of its Investment Team
CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., April 23, 2018 -- (Healthcare Sales & Marketing Network) -- Former Ariad Pharmaceuticals president and CEO Paris Panayiotopoulos has been appointed as an operating partner and member of the investment team... Biopharmaceuticals, Venture Capital, Personnel Clarus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Data from TOUR™ Observational Patient Registry Demonstrate Clinical Response Rates with VIBATIV® (telavancin) Treatment Range from 76.5 - 78.8% for Obese and Elderly Patient Subgroups Additional Study Results Demonstrate VIBATIV to Have 8- to 32-Fol... Biopharmaceuticals Theravance Biopharma, VIBATIV, telavancin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Dr. Philip Just Larsen Appointed Chief Scientific Officer (CSO)
AACHEN, Germany, April 23, 2018 -- (Healthcare Sales & Marketing Network) -- Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership o... Biopharmaceuticals, Personnel Grünenthal Group (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Shimadzu Corporation Releases New LIGHTVISION Near-infrared Fluorescence Imaging System
The LIGHTVISION near-infrared fluorescence imaging system is for visualizing lymph and blood vessels to support treatment of breast cancer KYOTO, Japan, April 23, 2018 -- (Healthcare Sales & Marketing Network) -- Shimadzu Corporation has entered the m... Devices, Product Launch Shimadzu, LIGHTVISION, near-infrared fluorescence, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Lugano, Switzerland April 20, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of AKYNZEO® (NEPA, a ... Biopharmaceuticals, Oncology, FDA Helsinn Group, AKYNZEO, fosnetupitant, palonosetron, antiemetic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer and Treasurer
NEW YORK, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today ... Biopharmaceuticals, Oncology, Personnel SELLAS Life Sciences, galinpepimut-S, Wilms Tumor 1 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

FDA Accepts Veloxis's Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR(R)
COPENHAGEN, Denmark, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company's supplemental New Drug Application (s... Biopharmaceuticals, FDA Veloxis Pharmaceuticals, ENVARSUS, tacrolimus, kidney transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
Midazolam Nasal Spray (USL261), is a nasally administered investigational midazolam formulation intended as a rescue treatment of acute repetitive seizures (ARS) in patients with epilepsy, which has completed Phase 3 clinical development and is ready to be... Biopharmaceuticals, Neurology, Acquisitions UCB , Proximagen, Midazolam, epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

Hill-Rom Enhances Spot(TM) Vision Screener To Serve Senior Population
New software advances early detection of vision loss among patients with pupil sizes as small as 3mm CHICAGO, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- Hill-Rom (NYSE: HRC) announced new enhancements to its Welch Allyn Spot™ Vision Sc... Devices, Ophthalmology, Product Launch Hill-Rom, Welch Allyn Spot, Vision Screener (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
Company Re-aligns Management Responsibilities PHILADELPHIA, April 20, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Maureen M. Cavanaugh to the newly created position, senior vice... Biopharmaceuticals, Generics, Personnel Lannett (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

Women Treated with Hologic's NovaSure(R) Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva
NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients MARLBOROUGH, Mass., April 19, 2018 -- (Healthcare Sales & Marketing Network) ... Devices, Interventional Hologic, NovaSure, endometrial ablation, Minerva (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

Emboline, Inc. Completes Funding Of Over $10 Million
Combination of $3 Million in Equity Financing and Conversion of $7 Million in Convertible Notes will Fund Clinical Trial for the Emboliner™ Embolic Protection Catheter SANTA CRUZ, Calif., April 19, 2018 -- (Healthcare Sales & Marketing Network) -- Embo... Devices, Interventional, Cardiology, Venture Capital Emboline, Emboliner, Embolic Protection, TAVR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies
PALO ALTO, Calif., April 19, 2018 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon™ 2.0 treatment system to expand its capabilities and ability to deliver high qual... Devices, Oncology Varian Medical Systems, Halcyon System, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 and Toca FC in the Greater China Region
Tocagen eligible to receive up to $127 million in upfront payment, development and commercial milestones, plus additional double-digit tiered sales royalties Upfront and near-term development milestones payments total up to $20 million SAN DIEGO and ... Biopharmaceuticals, Oncology, Licensing Tocagen, ApolloBio, immunotherapy, high grade glioma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

BD Unveils Suite of Diagnostic Informatics and Automation Innovations
BD Synapsys™ Microbiology Informatics Solution Among New Offerings Shown at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) FRANKLIN LAKES, N.J., April 19, 2018 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickin... Diagnostics BD , BD Synapsys, BD BACTEC FX, BD Kiestra (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

Management Change in Moberg Pharma
STOCKHOLM, April 19th, 2018 -- (Healthcare Sales & Marketing Network) -- Moberg Pharma AB (OMX: MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company part-time as Senior Adviser. On Octobe... Biopharmaceuticals, Personnel Moberg Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018
Collaboration with Sun Nuclear helps improve the quality, consistency and efficiency of radiation oncology treatment planning AMSTERDAM and BARCELONA, Spain, April 19, 2018 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG, AEX: PHI... Devices, Radiology, Oncology Royal Philips, Sun Nuclear, PlanIQ, Pinnacle3 16.2 Auto-Planning (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news

ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
New MR Pulse Sequences and Imaging Enhancements Expected to Provide Cutting-Edge Tumor and Healthy Tissue Visualization* CLEVELAND, April 18, 2018 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today new MR imaging ... Devices, Oncology ViewRay, MRIdian Linac, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 18, 2018 Category: Pharmaceuticals Source Type: news

Tetherex Pharmaceuticals, Inc. Completes $50M Series B Financing
Funding to support Phase 2 clinical trials of the company's PSGL-1 inhibitor, SelK2, in multiple indications OKLAHOMA CITY, April 18, 2018 -- (Healthcare Sales & Marketing Network) -- Tetherex Pharmaceuticals, Inc., a privately held biopharmaceutical c... Biopharmaceuticals, Venture Capital Tetherex Pharmaceuticals, venous thromboembolism, PSGL-1, SelK2 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 18, 2018 Category: Pharmaceuticals Source Type: news

Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance Its Robotic Platform for Microsurgery
CALCI, Italy, April 18, 2018 -- (Healthcare Sales & Marketing Network) -- Medical Microinstruments S.p.A. (MMI), an Italian company dedicated to improve clinical outcomes for patients undergoing microsurgery, today announces the completion of a €20M (appr... Devices, Surgery, Venture Capital Medical Microinstruments, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 18, 2018 Category: Pharmaceuticals Source Type: news

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
VANCOUVER, April 17, 2018 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollme... Biopharmaceuticals, Cardiology Cardiome Pharma, BRINAVESS, vernakalant, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

King-Devick technologies receives FDA clearance for K-D Balance(TM) App
This new objective balance measure utilizing a smart phone will be available in May 2018 OAKBROOK TERRACE, Ill., April 17, 2018 -- (Healthcare Sales & Marketing Network) -- King-Devick technologies, inc., a leading provider of evidence- based assessmen... Devices, FDA King-Devick Technologies, K-D Balance (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

Xcision Announces Leading Italian Hospital to Acquire GammaPod(TM) Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., April 17, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC today announced that Azienda Universitaria Integrata di Udine (ASUIUD) in Italy will acquire the GammaPod™ Stereotactic Radiotherapy System, a new trea... Devices, Oncology Xcision Medical Systems, GammaPod, Stereotactic Radiotherapy System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2018 Category: Pharmaceuticals Source Type: news

TELA Bio Announces Series B Investment by Checkmate Capital
Surgical reconstruction company looks to forge long-term relationship with strategic investment group. MALVERN, Pa., April 16, 2018 -- (Healthcare Sales & Marketing Network) -- TELA Bio®, Inc., a surgical reconstruction company leading the developm... Devices, Surgery, Venture Capital TELA Bio, OviTex, Reinforced BioScaffolds (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Phase I data show early efficacy in the majority of patients and a very favourable safety profile HASSELT, Belgium and CHEPSTOW, Wales, April 16, 2018 -- (Healthcare Sales & Marketing Network) -- Apitope, a clinical stage biotech company developing pot... Biopharmaceuticals Apitope, Graves' Disease, Multiple Sclerosis, autoimmune disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
First moderate complexity molecular test for sexually transmitted infections on fully automated, high throughput platform Broad set of urogenital sample claims ensure greatest flexibility for patient access New test for most common sexually transmitt... Diagnostics, FDA Roche Group, cobas, cobas CT/NG, chlamydia, gonorrhoeae (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 16, 2018 Category: Pharmaceuticals Source Type: news

Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
HOUSTON, April 13, 2018 -- (Healthcare Sales & Marketing Network) -- Today, Cellenkos Inc. announced the appointment of Alick Sun as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company contin... Biopharmaceuticals, Personnel Cellenkos, cord blood, regulatory T cells, (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

Medisystems Announces US Release of MasterGuard(R) Plus
Innovative AVF needle guard includes enhancements designed to prevent needlesticks LAWRENCE, Mass., April 13, 2018 -- (Healthcare Sales & Marketing Network) -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advan... Devices, Drug Delivery, Product Launch NxStage Medical, Medisystems, MasterGuard, needlestick, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

Ampio Updates Regulatory, Clinical and NYSE Activities
ENGLEWOOD, Colo., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has begun preliminary discussions with the Food and Drug Administration on details of the Biologics Lice... Biopharmaceuticals, FDA Ampio Pharmaceuticals, Ampion, osteoarthritis, albumin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2018 Category: Pharmaceuticals Source Type: news

HeartStitch(R) Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure
HeartStitch®, Inc. Announces CE Mark for its Minimally Invasive Trans-Apical Access and Closure Device ZWICKAU, Germany, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- HeartStitch® Trans-Apical Access and Closure device provides sa... Devices, Cardiology, Regulatory HeartStitch, NobleStitch, vascular suture, trans-apical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
IDx-DR becomes the first autonomous, AI-based diagnostic system authorized for marketing by the FDA CORALVILLE, Iowa, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- IDx, a privately-held AI diagnostics company, announced today that the U.S... Devices, Ophthalmology, FDA, Product Launch IDx, IDx-DR, Diabetic Retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
ANDOVER, Mass., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company that is transforming the important therapy of solid organ transplantation for patients with end-stage lung, heart and liver failure... Devices, Surgery, FDA TransMedics, Organ Care System, lung transplant, organ transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer
NESS ZIONA, Israel, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant hum... Regenerative Medicine, Personnel CollPlant, rhCollagen, Vergenix, VergenixSTR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer
MINNEAPOLIS, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Conventus Orthopaedics, a medical device company revolutionizing fracture repair surgery, today announced the appointment of Jonathan Isenburg as its new Chief Financial Officer. Mr... Devices, Orthopaedic, Personnel Conventus Orthopaedics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Elekta Expands the MOSAIQ Ecosystem of Complementary Applications With Strategic Investment in PalabraApps
Enhanced collaboration designed to advance Elekta's clinical workflow productivity and mobility offerings ATLANTA, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) today announced that it is making a strategic investment i... Devices, Oncology, Venture Capital Elekta, PalabraApps, MOSAIQ, radiotherapy, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2018 Category: Pharmaceuticals Source Type: news

Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
AUSTIN, Texas and CAMBRIDGE, Mass., April 11, 2018 -- (Healthcare Sales & Marketing Network) -- Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology plat... Biopharmaceuticals, Oncology, Drug Delivery, Personnel Genprex, Oncoprex, immunogene therapy, non-small cell lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 11, 2018 Category: Pharmaceuticals Source Type: news